Newswise News from Roswell Park Comprehensive Cancer Center display Latest news from Roswell Park Comprehensive Cancer Center on Newswise en-us Copyright 2025 Newswise Newswise News from Roswell Park Comprehensive Cancer Center 115 31 / /images/newswise-logo-rss.gif Roswell Park Researchers to Discuss Recent Discoveries and Critical Issues in Oncology at AACR 2025 /articles/roswell-park-researchers-to-discuss-recent-discoveries-and-critical-issues-in-oncology-at-aacr-2025/?sc=rsin /articles/roswell-park-researchers-to-discuss-recent-discoveries-and-critical-issues-in-oncology-at-aacr-2025/?sc=rsin Thu, 17 Apr 2025 20:55:38 EST Researchers from Roswell Park will report their latest findings to colleagues from around the world at the 2025 annual meeting of the American Association for Cancer Research (AACR) in Chicago, Illinois, April 25-30. Roswell Park Comprehensive Cancer Center Roswell Park Reports Extraordinary Outcomes for Robot-Assisted Minimally Invasive Esophagectomy /articles/roswell-park-reports-extraordinary-outcomes-for-robot-assisted-minimally-invasive-esophagectomy/?sc=rsin /articles/roswell-park-reports-extraordinary-outcomes-for-robot-assisted-minimally-invasive-esophagectomy/?sc=rsin Thu, 10 Apr 2025 18:10:30 EST Roswell Park Comprehensive Cancer Center achieved "textbook" positive outcomes for 90% of 150 consecutive minimally invasive esophagectomies (RAMIE) performed between 2020-2024, as reported in a study in the Journal of Gastrointestinal Surgery. Roswell Park Comprehensive Cancer Center Roswell Park-Led Research Reveals a Hidden Vulnerability of Lung Cancer /articles/roswell-park-led-research-reveals-a-hidden-vulnerability-of-lung-cancer/?sc=rsin /articles/roswell-park-led-research-reveals-a-hidden-vulnerability-of-lung-cancer/?sc=rsin Thu, 10 Apr 2025 17:55:38 EST Treatment resistance and relapse in the most common type of lung cancer can be traced to a protein called agrin, according to a preclinical study led by Roswell Park. Results of the study, led by Sayan Chakraborty, PhD, Assistant Professor of Oncology at Roswell Park, appear in Advanced Science. Roswell Park Comprehensive Cancer Center In tribute to Thomas B. Tomasi Jr., MD, PhD, 1927-2025 /articles/in-tribute-to-thomas-b-tomasi-jr-md-phd-1927-2025/?sc=rsin /articles/in-tribute-to-thomas-b-tomasi-jr-md-phd-1927-2025/?sc=rsin Thu, 10 Apr 2025 17:55:19 EST Thomas B. Tomasi Jr., MD, PhD, who led Roswell Park as President and CEO from 1986-1996, died March 23, 2025, at age 97. His tenure marked a renaissance at Roswell Park that elevated it to a place among the nation's top cancer centers. Roswell Park Comprehensive Cancer Center Brain Imaging Plus Virtual Reality Shows Promise for Effectively Managing Cancer Pain /articles/brain-imaging-plus-virtual-reality-shows-promise-for-effectively-managing-cancer-pain/?sc=rsin /articles/brain-imaging-plus-virtual-reality-shows-promise-for-effectively-managing-cancer-pain/?sc=rsin Thu, 10 Apr 2025 17:50:35 EST A clinical research study led by Roswell Park experts outlines a new way to measure pain in cancer patients and treat it effectively without opioids. The new study advances the goal of better managing cancer pain by incorporating both non-invasive brain imaging technology and virtual reality (VR). Roswell Park Comprehensive Cancer Center Society of Surgical Oncology Highlights Roswell Park Experts at 2025 Annual Meeting /articles/society-of-surgical-oncology-highlights-roswell-park-experts-at-2025-annual-meeting/?sc=rsin /articles/society-of-surgical-oncology-highlights-roswell-park-experts-at-2025-annual-meeting/?sc=rsin Thu, 10 Apr 2025 17:45:15 EST Cancer surgery leaders from Roswell Park will share their expertise with other cancer surgeons from around the world during the annual meeting of the Society of Surgical Oncology at the Tampa Convention Center March 27-29. Roswell Park Comprehensive Cancer Center Roswell Park's Intensive Care Unit Earns National Recognition for Exceptional Patient Outcomes /articles/roswell-park-s-intensive-care-unit-earns-national-recognition-for-exceptional-patient-outcomes/?sc=rsin /articles/roswell-park-s-intensive-care-unit-earns-national-recognition-for-exceptional-patient-outcomes/?sc=rsin Mon, 17 Mar 2025 19:15:49 EST Roswell Park's Intensive Care Unit Earns National Recognition for Exceptional Patient Outcomes Roswell Park Comprehensive Cancer Center Roswell Park Named One of Only 37 Optum Cancer Centers of Excellence for Adult and Pediatric Patients /articles/roswell-park-named-one-of-only-37-optum-cancer-centers-of-excellence-for-adult-and-pediatric-patients/?sc=rsin /articles/roswell-park-named-one-of-only-37-optum-cancer-centers-of-excellence-for-adult-and-pediatric-patients/?sc=rsin Mon, 17 Mar 2025 18:50:30 EST Roswell Park Named One of Only 37 Optum Cancer Centers of Excellence for Adult and Pediatric Patients Roswell Park Comprehensive Cancer Center Roswell Park Team Gets the Call: 'You've Earned Magnet Recognition for Nursing Excellence' /articles/roswell-park-team-gets-the-call-you-ve-earned-magnet-recognition-for-nursing-excellence/?sc=rsin /articles/roswell-park-team-gets-the-call-you-ve-earned-magnet-recognition-for-nursing-excellence/?sc=rsin Tue, 25 Feb 2025 17:55:03 EST BUFFALO, N.Y. -- Today, on a call with officials from the American Nurses Credentialing Center (ANCC), nurses from teams across Roswell Park Comprehensive Cancer Center learned that they earned a prestigious distinction: Magnet(r) Recognition for nursing excellence. The designation follows an in-depth review by the ANCC, and signifies that Roswell Park nurses have met stringent standards for nursing excellence in patient care delivery. Roswell Park Comprehensive Cancer Center Roswell Park-Led Team Proposes CDK2 Enzyme as New Target for Cancer Therapy /articles/roswell-park-led-team-proposes-cdk2-enzyme-as-new-target-for-cancer-therapy/?sc=rsin /articles/roswell-park-led-team-proposes-cdk2-enzyme-as-new-target-for-cancer-therapy/?sc=rsin Fri, 14 Feb 2025 10:20:45 EST A new study published in the journal Nature Communications, led by Agnieszka Witkiewicz, MD, and Erik Knudsen, PhD, of Roswell Park, highlights the therapeutic impact of CDK2 inhibitors as treatment for cancers including some breast and pancreatic tumors. Roswell Park Comprehensive Cancer Center Tandem 2025: Roswell Park Team Creates Predictive Model to Inform Care of Lymphoma Patients /articles/tandem-2025-roswell-park-team-creates-predictive-model-to-inform-care-of-lymphoma-patients/?sc=rsin /articles/tandem-2025-roswell-park-team-creates-predictive-model-to-inform-care-of-lymphoma-patients/?sc=rsin Tue, 04 Feb 2025 21:05:56 EST Roswell Park experts will share new discoveries and insights at the 2025 Tandem Transplantation & Cellular Therapy Meetings of the American Society for Transplantation and Cellular Therapy (ASTCT) and Center for International Blood and Marrow Transplant Research (CIBMTR) Feb. 12-15 in Honolulu. Roswell Park Comprehensive Cancer Center Changes in Microbiome Predict Risk for Sexually Transmitted Infections /articles/changes-in-microbiome-predict-risk-for-sexually-transmitted-infections/?sc=rsin /articles/changes-in-microbiome-predict-risk-for-sexually-transmitted-infections/?sc=rsin Wed, 15 Jan 2025 17:30:09 EST Researchers at Albert Einstein College of Medicine, Roswell Park Comprehensive Cancer Center and the Icahn School of Medicine at Mount Sinai have found that bacterial vaginosis consists of two distinct subtypes -- one of which significantly increases the risk of developing chlamydia infections Roswell Park Comprehensive Cancer Center Roswell Park Team Identifies New Cause of Chemotherapy Resistance in Triple-Negative Breast Cancer /articles/roswell-park-team-identifies-new-cause-of-chemotherapy-resistance-in-triple-negative-breast-cancer/?sc=rsin /articles/roswell-park-team-identifies-new-cause-of-chemotherapy-resistance-in-triple-negative-breast-cancer/?sc=rsin Fri, 10 Jan 2025 20:05:47 EST Researchers at Roswell Park Comprehensive Cancer Center have identified a cause of resistance to doxorubicin in triple-negative breast cancer. The team's new study in Scientific Reports points to a new strategy for overcoming this resistance to treatment, using drugs known as IMPDH2 inhibitors. Roswell Park Comprehensive Cancer Center Buffalo Spree Names Record 143 Roswell Park Physicians as Top Doctors for 2025 /articles/buffalo-spree-names-record-143-roswell-park-physicians-as-top-doctors-for-2025/?sc=rsin /articles/buffalo-spree-names-record-143-roswell-park-physicians-as-top-doctors-for-2025/?sc=rsin Mon, 30 Dec 2024 16:20:08 EST As the year comes to a close, Roswell Park Comprehensive Cancer Center honors the 143 physicians across 35 specialties named to Buffalo Spree magazine's Top Doctors list for 2025. The annual list is compiled through surveys submitted by Western New York physicians. Roswell Park Comprehensive Cancer Center Roswell Park Team Discovers New Treatment Target for Neuroendocrine Prostate Cancer /articles/roswell-park-team-discovers-new-treatment-target-for-neuroendocrine-prostate-cancer/?sc=rsin /articles/roswell-park-team-discovers-new-treatment-target-for-neuroendocrine-prostate-cancer/?sc=rsin Wed, 18 Dec 2024 20:05:13 EST A team of researchers at Roswell Park , led by Dhyan Chandra, PhD, has discovered a new therapeutic target for neuroendocrine prostate cancer, a rare and hard-to-treat form of prostate cancer. Their findings, newly published in the journal Oncogene, suggest that a set of processes known as the mitochondrial unfolded protein response, could be an Achilles' heel for this often-deadly cancer type, and may point the way to a new treatment approach. Roswell Park Comprehensive Cancer Center Governor Hochul Celebrates the Opening Of New York's First Cell and Gene Therapy Hub at Roswell Park Comprehensive Cancer Center in Buffalo /articles/governor-hochul-celebrates-the-opening-of-new-york-s-first-cell-and-gene-therapy-hub-at-roswell-park-comprehensive-cancer-center-in-buffalo/?sc=rsin /articles/governor-hochul-celebrates-the-opening-of-new-york-s-first-cell-and-gene-therapy-hub-at-roswell-park-comprehensive-cancer-center-in-buffalo/?sc=rsin Mon, 16 Dec 2024 21:10:27 EST Governor Kathy Hochul today celebrated the opening of the Roswell Park GMP Engineering and Cell Manufacturing Facility, New York's first cell and gene therapy hub, located at Roswell Park Comprehensive Cancer Center in Buffalo. The $98 million facility will create new jobs, help to support the research and development of life-saving cell and gene therapies at Roswell, significantly grow its well-established research capabilities, and establish Roswell as one of the premier cell therapy discovery and development institutions in the nation. The expansion also realizes Governor Hochul's 2023 State of the State commitment to bolster the state's leadership in the fast-growing CGT sector through establishment of an Upstate cell and gene therapy hub to catalyze its growth in western NY. The GEM facility meets U.S. FDA Good Manufacturing Practice standards for manufacture of clinical cell therapy products, positioning the Roswell Park team to be a multifaceted resource for patients, care teams Roswell Park Comprehensive Cancer Center Roswell Park Team Identifies Factors That Boost Effectiveness of Immunotherapy in Recurrent Ovarian Cancer /articles/roswell-park-team-identifies-factors-that-boost-effectiveness-of-immunotherapy-in-recurrent-ovarian-cancer/?sc=rsin /articles/roswell-park-team-identifies-factors-that-boost-effectiveness-of-immunotherapy-in-recurrent-ovarian-cancer/?sc=rsin Thu, 12 Dec 2024 20:35:58 EST A study led by Roswell Park provides new insight into the complex interactions of the "tumor-immune-gut axis," and its role in influencing immunotherapy responses in patients with recurrent ovarian cancer. Newly published in Nature Communications, the findings emphasize the role of the patient's microbiome -- the collection of microorganisms in the body --and lay the groundwork for future clinical trials aimed at improving treatment outcomes. Roswell Park Comprehensive Cancer Center Could Venetoclax Improve Outcomes of CAR T for Patients with Resistant B-Cell Lymphomas? New Insights at ASH /articles/could-venetoclax-improve-outcomes-of-car-t-for-patients-with-resistant-b-cell-lymphomas-new-insights-at-ash/?sc=rsin /articles/could-venetoclax-improve-outcomes-of-car-t-for-patients-with-resistant-b-cell-lymphomas-new-insights-at-ash/?sc=rsin Mon, 09 Dec 2024 19:30:00 EST About a third of patients with diffuse large B cell lymphoma (DLBCL), a fast-growing form of lymphoma, will see their disease advance or recur following treatment. Seeking a new treatment strategy that might boost the effectiveness of existing DLBCL therapies, a team from Roswell Park has been working to understand the underlying mechanisms of the targeted chemotherapy venetoclax. Their findings, to be presented during a talk today at the 66th annual meeting of the American Society of Hematology (ASH) in San Diego, California, provide strong preclinical evidence that adding venetoclax to standard treatment may improve outcomes in patients with treatment-resistant B-cell lymphomas. Roswell Park Comprehensive Cancer Center Resistance Training Can Reduce Fatigue, Pain in Multiple Myeloma Patients, Roswell Park Team Shows /articles/resistance-training-can-reduce-fatigue-pain-in-multiple-myeloma-patients-roswell-park-team-shows/?sc=rsin /articles/resistance-training-can-reduce-fatigue-pain-in-multiple-myeloma-patients-roswell-park-team-shows/?sc=rsin Sun, 08 Dec 2024 16:30:07 EST Researchers from Roswell Park Comprehensive Cancer Center will present compelling findings showcasing significant benefits of resistance training for patients with multiple myeloma, in a talk at the 66th American Society of Hematology (ASH) Annual Meeting. The study, led by Jens Hillengass, MD, PhD, and Janine Joseph, MS, MBA, presents new evidence documenting that targeted exercise regimens can alleviate fatigue, improve sleep and reduce pain, offering new hope for enhancing quality of life in cancer care. Roswell Park Comprehensive Cancer Center Roswell Park Experts Report Insights on CAR T for Follicular Lymphoma, KEYNOTE-667 Combo in Hodgkin Lymphoma /articles/roswell-park-experts-report-insights-on-car-t-for-follicular-lymphoma-keynote-667-combo-in-hodgkin-lymphoma/?sc=rsin /articles/roswell-park-experts-report-insights-on-car-t-for-follicular-lymphoma-keynote-667-combo-in-hodgkin-lymphoma/?sc=rsin Sun, 08 Dec 2024 12:30:00 EST The results of two important lymphoma studies led by experts at Roswell Park Comprehensive Cancer Center will be presented during oral abstract sessions this morning at the 66th annual meeting of the American Society of Hematology (ASH) in San Diego, California. Lymphoma is a type of blood cancer that causes white blood cells called lymphocytes to grow out of control and behave abnormally. Roswell Park Comprehensive Cancer Center